SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer
A phase 2 trial of SHR-8068, Adebrelimab, Cisplatin, Gemcitabine and Bevacizumab in biliary tract cancer, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., active and no longer recruiting.
Overview
SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer is a phase 2 interventional study registered as NCT06465563 by Suzhou Suncadia Biopharmaceuticals Co., Ltd., with 93 participants enrolled, started 2024-07-01 and due to reach its primary completion in 2026-12-30. Interventions recorded: SHR-8068, Adebrelimab, Cisplatin, Gemcitabine and Bevacizumab Injection.
Similar pages
not linked directly; found by shared links- TrialA Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
- TrialA Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Cisplatin and the tag pipeline.
- TrialA Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Cisplatin and the tag pipeline.
- TrialStudy of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Cisplatin and the tag pipeline.
- TrialA Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Bevacizumab and the tag pipeline.
- TrialA Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Gemcitabine and the tag pipeline.
- TrialHRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Gemcitabine and the tag pipeline.